Decoy Therapeutics, Inc. (DCOY)
3.11
-0.09
(-2.81%)
USD |
NASDAQ |
Aug 24, 16:00
3.11
0.00 (0.00%)
Pre-Market: 20:00
Decoy Therapeutics Total Assets (Quarterly) : 9.001M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.001M |
| March 31, 2026 | 8.423M |
| December 31, 2025 | 11.06M |
| September 30, 2025 | 6.097M |
| June 30, 2025 | 1.393M |
| March 31, 2025 | 2.339M |
| December 31, 2024 | 3.023M |
| September 30, 2024 | 3.859M |
| June 30, 2024 | 3.554M |
| March 31, 2024 | 4.884M |
| December 31, 2023 | 6.586M |
| September 30, 2023 | 8.404M |
| June 30, 2023 | 12.06M |
| March 31, 2023 | 10.06M |
| December 31, 2022 | 14.65M |
| September 30, 2022 | 19.72M |
| June 30, 2022 | 33.65M |
| March 31, 2022 | |
| December 31, 2021 | 40.83M |
| September 30, 2021 | 44.26M |
| June 30, 2021 | 47.40M |
| March 31, 2021 | 50.77M |
| December 31, 2020 | 24.93M |
| September 30, 2020 | 23.06M |
| Date | Value |
|---|---|
| June 30, 2020 | 18.56M |
| March 31, 2020 | 20.07M |
| December 31, 2019 | 13.89M |
| September 30, 2019 | 14.46M |
| June 30, 2019 | 7.137M |
| March 31, 2019 | 8.184M |
| December 31, 2018 | 6.614M |
| September 30, 2018 | 13.94M |
| June 30, 2018 | 17.21M |
| March 31, 2018 | 26.03M |
| December 31, 2017 | 34.99M |
| September 30, 2017 | 41.21M |
| June 30, 2017 | 49.63M |
| March 31, 2017 | 55.50M |
| December 31, 2016 | 63.22M |
| September 30, 2016 | 69.95M |
| June 30, 2016 | 78.23M |
| March 31, 2016 | 87.25M |
| December 31, 2015 | 95.07M |
| September 30, 2015 | 100.76M |
| June 30, 2015 | 107.20M |
| March 31, 2015 | 111.94M |
| December 31, 2014 | 35.61M |
| September 30, 2014 | 36.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Palatin Technologies, Inc. | 13.23M |
| Unicycive Therapeutics, Inc. | 72.03M |
| Nuvectis Pharma, Inc. | 22.38M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.680M |
| Shareholders Equity (Quarterly) | 4.321M |
| Current Ratio | 1.832 |
| Net Debt Paydown Yield | 0.59% |